Intensive vs liberalized phosphate control in hemodialysis recipients

血液透析接受者的强化磷酸盐控制与自由化磷酸盐控制

• 批准号: 276358
• 负责人: Wald Ron
• 金额: $ 7.29万
• 依托单位: Unity Health Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-09-01 至 2013-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=276358&lang=en
• 关键词: Clinical Trial; Hemodialysis; Hyperphosphatemia; Phosphate Binders; Clinical Trial; Hemodialysis; Hyperphosphatemia; Phosphate Binders

Patients with kidney failure who require long-term dialysis are at high risk of dying of cardiovascular causes. In such individuals, phosphate levels in the blood tend to be high. These high levels may be damaging to the heart, blood vessels and bone. Pat

需要长期透析的肾衰竭患者患心血管病毒的高风险。在这样的个体中，血液中的磷酸盐水平往往很高。这些高水平可能会损害心脏，血管和骨骼。拍